Markets.com Logo

MREO

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.614$
  • Previous Close
    1.6648$
  • 52 Week Change
    3.48$
  • Day Range
    -0.05$
  • 52 Week High/Low
    1.47$ - 4.95$
  • Dividend Per Share
    --
  • Market cap
    262 M$
  • EPS
    -0.02
  • Beta
    0.416
  • Volume
    --

About

MREO.US represents the common stock of Mereo BioPharma Group plc traded on the Nasdaq Stock Market. Mereo BioPharma is a biopharmaceutical company focused on the development of innovative therapeutics for rare diseases and oncology. The .US suffix indicates the stock is traded on a United States exchange. Investors can buy and sell MREO.US shares through brokerage accounts that offer access to the Nasdaq.

Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence

Noah Lee|--

Global Markets Show Resilience Amidst Iran Conflict, But Underlying Risks Persist

Emma Rose|--

Iran War Threatens US Labor Market's 'Wonderful Balance': A Deep Dive

Emma Rose|--

Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment

Sophia Claire|--

US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks

Sophia Claire|--

Global Debt Crisis Deepens Amidst Iran Conflict and Fiscal Fragility

Ava Grace|--

Apple's Strategic Pivot: MacBook Neo, Supply Chain Tactics, and Foldable Phone Hurdles

Emma Rose|--

Factors

Market Sentiment: Overall investor optimism or pessimism influences buying/selling pressure, impacting the stock price.

Company Performance: Revenue, earnings, and growth prospects directly affect investor confidence and valuation.

Industry Trends: Developments in the pharmaceutical and biotechnology sectors can shift investor focus and valuations.

Regulatory Changes: New regulations or approvals related to MREO's products or clinical trials can cause volatility.

Economic Conditions: Broad economic factors such as interest rates, inflation, and GDP growth can impact investment decisions.

Competition: The presence and performance of competitors can affect MREO's market share and pricing power.

Clinical Trial Results: Positive or negative data from clinical trials for MREO's drug candidates has a significant impact.

People Also Watch

Latest news

Close Coordination Between Israel and US on Iran Nuclear Talks Highlighted

Noah Lee|--

US-Iran Talks Show Progress Towards Ceasefire Framework Agreement

Liam James|--

Federal Reserve Independence Under Historic Test: Navigating Democratic Legitimacy and Political Pressure

Liam James|--

Latest Education Articles

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Julian Parker|--
Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Julian Parker|--
Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Frances Wang|--
Recommended Topics